CKD Corporation

6407

JP3346800000

Industrial Machinery & Equipment

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-19 am EDT			5-day change	1st Jan Change
2,889 ^JPY	-5.12%		-8.43%	+13.74%

Apr. 15	AstraZeneca: expects a sharp rise in kidney disease	CF
Apr. 11	TVS Supply Chain's Supply of CKD Kits to TVS Motor Crosses 500,000	MT

CKD Corporation Determines Dividend for the Fiscal Year Ended March 31, 2021

May 12, 2021

CKD Corporation determined dividend for the fiscal year ended March 31, 2021 will be ¥17 per share, increased by ¥8 per share from the previous forecast of ¥9 per share.

Latest news about CKD Corporation

AstraZeneca: expects a sharp rise in kidney disease	Apr. 15	CF
TVS Supply Chain's Supply of CKD Kits to TVS Motor Crosses 500,000	Apr. 11	MT
Jefferies Upgrades CKD to Buy From Hold, Adjusts Price Target to 4,000 Yen From 2,600 Yen	Mar. 05	MT
Novo Nordisk: EU could authorize Wegovy by April	Feb. 23	CF
Novo Nordisk: EU authorization for Wegovy by April?	Feb. 23	CF
Disc Medicine Says FDA Grants Fast Track Designation for Investigational Treatment of Chronic Kidney Disease, Anemia	Feb. 20	MT
Jefferies Downgrades CKD to Hold From Buy, Adjusts Price Target to 2,600 Yen From 2,300 Yen	Feb. 08	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD	Jan. 31	MT
FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia	Jan. 19	MT
FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia	Jan. 19	MT
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease	Jan. 03	MT
Hansoh Pharma's Three Drugs Added to China’s National Reimbursement Drug List	Dec. 14	MT
AstraZeneca Discontinues Two Phase 3 Evidence Trials of Lokelma in Managing Hyperkalemia	Dec. 01	MT
AstraZeneca: discontinuation of two phase III trials for Lokelma	Dec. 01	CF
Miners give FTSE 100 boost thanks to China PMI	Dec. 01	AN
AstraZeneca discontinues two phase III evidence trials for Lokelma	Dec. 01	AN
AstraZeneca Ends Two Late-stage Studies of Hyperkalemia Drug Lokelma on Delayed Schedules	Dec. 01	MT
Stocks called higher; UK house prices fall annually	Dec. 01	AN
AstraZeneca to scrap two trials on drug that curbs potassium	Dec. 01	RE
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast	Nov. 30	MT
Foyou Pharma Gets Nod to Market Roxadustat API	Nov. 22	MT
Jefferies Adjusts CKD’s Price Target to 2,300 Yen From 2,400 Yen, Keeps at Buy	Nov. 13	MT
Chong Kun Dang Pharmaceutical Inks Largest-Ever Technology Transfer Agreement with Novartis	Nov. 08	MT
AstraZeneca Drug Combo Found to Reduce Disease Marker Associated with Chronic Kidney Disease	Nov. 03	MT
AstraZeneca plans next phase of trial on kidney drug combination data	Nov. 03	AN

CKD Corporation is engaged in the manufacture and sale of automatic machinery and equipment. The Automatic Machinery segment offers automatic packaging systems, image processing inspection systems, lithium-ion battery manufacturing systems, three-dimensional solder printing inspection machines, lighting manufacturing systems and capacitor manufacturing systems. The Machinery segment offers index units, direct drive motors, pick-and-place units, pneumatic directional control valves, manual switching valves, pneumatic cylinders, cylinders with valve, special cylinders, electric actuators, cylinders with multi-function, filters, regulators, lubricators, fittings, speed controllers, refrigeration type dryers, dry type dryers, membrane type dryers, mainline filters, flow sensors, pressure sensors and various valves. The Company also involves in the insurance agency and factoring businesses.

Sector

Industrial Machinery & Equipment

Calendar

2024-05-09 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for CKD Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2,889 JPY

Average target price

3,218 JPY

Spread / Average Target

+11.38%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Machinery

	1st Jan change	Capi.
CKD CORPORATION	+13.74%	1.25B
NORDSON CORPORATION	-1.73%	14.85B
HAITIAN INTERNATIONAL HOLDINGS LIMITED	+32.51%	5.22B
WUXI LEAD INTELLIGENT EQUIPMENT CO.,LTD.	-10.98%	4.91B
VALMET OYJ	-3.91%	4.93B
SUZHOU MAXWELL TECHNOLOGIES CO., LTD.	-12.49%	4.35B
KRONES AG	+9.84%	4.14B
TOMRA SYSTEMS ASA	+21.18%	4.02B
IHI CORPORATION	+36.62%	3.69B
KADANT INC.	+0.60%	3.3B

Industrial Machinery

CKD Corporation

Equities

6407

JP3346800000

Industrial Machinery & Equipment

CKD Corporation Determines Dividend for the Fiscal Year Ended March 31, 2021

Latest news about CKD Corporation

Chart CKD Corporation

Company Profile

Income Statement Evolution

Ratings for CKD Corporation

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Industrial Machinery